Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Environmental toxins can cause a model of Parkinson’s disease in rats

21.06.2004


Scientists have induced a movement disorder in rats that closely resembles Parkinson’s disease in humans. The study, published June 21, 2004, in the online edition of the Annals of Neurology, suggests that natural toxins found in the environment could contribute to the development of this debilitating movement disorder. The full study will be available via Wiley InterScience.

The compounds, called proteasome inhibitors, can be produced by bacteria and fungi. Man-made proteasome inhibitors may also find their way into the environment.

"These results suggest that we should determine how widespread these toxins are in the environment, how humans are exposed to them, and how such exposures correlate with the incidence of Parkinson’s disease," said lead author Kevin St. P. McNaught, PhD, of the Mount Sinai School of Medicine in New York City.



Ironically, proteasome inhibitors are currently being used as a treatment for cancer.

Parkinson’s disease afflicts up to a million Americans. Symptoms can include slowness of movement, tremor when at rest, muscle rigidity abnormalities of gait. Parkinson’s symptoms can be traced to the progressive death of nerve cells, most prominently in an area of the brain called the substantia nigra accompanied by a loss of the brain chemical dopamine.

What kills the nerve cells in Parkinson’s is not known, but it is suspected that the majority of cases are related to environmental factors that could include exposure to toxins.

Several animal models of Parkinson’s disease exist, but none recapitulate the features of the disease as closely as the present model, said C. Warren Olanow, M.D., Ph.D., chair of neurology at Mount Sinai, and a co-author of the study.

Proteasomes are responsible for eliminating abnormal proteins from cells, acting like a garbage disposal system. Based on growing evidence that proteasomes are defective in Parkinson’s disease, McNaught and colleagues examined the effects of experimentally interfering with proteasomes in laboratory rats, using both man-made and naturally occurring proteasome inhibitors.

About two weeks after receiving injections of proteasome inhibitors, the rats began to show symptoms similar to Parkinson’s disease, including slowness of movement, rigidity, and tremor. "These symptoms gradually worsened over a period of months, and could be reversed with drugs that are used to treat Parkinson’s patients," said McNaught.

Imaging studies of the living animals’ brains demonstrated changes in a pattern identical to that seen in Parkinson’s disease. Similarly, autopsy studies on the animals’ brains demonstrated a reduction in brain levels of dopamine and nerve cell loss in a pattern that closely resembled Parkinson’s disease.

"We create animal models of a disease for several reasons," said Dr. Olanow. "We can use the model to find underlying mechanisms responsible for the disease, identify targets for drug development, and test any new therapies. Our present model should facilitate accomplishing these goals in Parkinson’s disease."

McNaught notes that epoxomicin, one of the most potent proteasome inhibitors known, is produced by the common actinomycetes bacteria, which is found in soil and well water throughout the world.

"It’s only speculation at this point, but the fact that living in rural areas and drinking well water has been reported to be associated with higher rates of Parkinson’s disease could be related to higher levels of proteasome inhibitors found in these areas" said Dr. Olanow.

David Greenberg | EurekAlert!
Further information:
http://www.wiley.com
http://www.interscience.wiley.com

More articles from Studies and Analyses:

nachricht Multi-year study finds 'hotspots' of ammonia over world's major agricultural areas
17.03.2017 | University of Maryland

nachricht Diabetes Drug May Improve Bone Fat-induced Defects of Fracture Healing
17.03.2017 | Deutsches Institut für Ernährungsforschung Potsdam-Rehbrücke

All articles from Studies and Analyses >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Giant Magnetic Fields in the Universe

Astronomers from Bonn and Tautenburg in Thuringia (Germany) used the 100-m radio telescope at Effelsberg to observe several galaxy clusters. At the edges of these large accumulations of dark matter, stellar systems (galaxies), hot gas, and charged particles, they found magnetic fields that are exceptionally ordered over distances of many million light years. This makes them the most extended magnetic fields in the universe known so far.

The results will be published on March 22 in the journal „Astronomy & Astrophysics“.

Galaxy clusters are the largest gravitationally bound structures in the universe. With a typical extent of about 10 million light years, i.e. 100 times the...

Im Focus: Tracing down linear ubiquitination

Researchers at the Goethe University Frankfurt, together with partners from the University of Tübingen in Germany and Queen Mary University as well as Francis Crick Institute from London (UK) have developed a novel technology to decipher the secret ubiquitin code.

Ubiquitin is a small protein that can be linked to other cellular proteins, thereby controlling and modulating their functions. The attachment occurs in many...

Im Focus: Perovskite edges can be tuned for optoelectronic performance

Layered 2D material improves efficiency for solar cells and LEDs

In the eternal search for next generation high-efficiency solar cells and LEDs, scientists at Los Alamos National Laboratory and their partners are creating...

Im Focus: Polymer-coated silicon nanosheets as alternative to graphene: A perfect team for nanoelectronics

Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are less stable. Now researchers at the Technical University of Munich (TUM) have, for the first time ever, produced a composite material combining silicon nanosheets and a polymer that is both UV-resistant and easy to process. This brings the scientists a significant step closer to industrial applications like flexible displays and photosensors.

Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are...

Im Focus: Researchers Imitate Molecular Crowding in Cells

Enzymes behave differently in a test tube compared with the molecular scrum of a living cell. Chemists from the University of Basel have now been able to simulate these confined natural conditions in artificial vesicles for the first time. As reported in the academic journal Small, the results are offering better insight into the development of nanoreactors and artificial organelles.

Enzymes behave differently in a test tube compared with the molecular scrum of a living cell. Chemists from the University of Basel have now been able to...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

International Land Use Symposium ILUS 2017: Call for Abstracts and Registration open

20.03.2017 | Event News

CONNECT 2017: International congress on connective tissue

14.03.2017 | Event News

ICTM Conference: Turbine Construction between Big Data and Additive Manufacturing

07.03.2017 | Event News

 
Latest News

Argon is not the 'dope' for metallic hydrogen

24.03.2017 | Materials Sciences

Astronomers find unexpected, dust-obscured star formation in distant galaxy

24.03.2017 | Physics and Astronomy

Gravitational wave kicks monster black hole out of galactic core

24.03.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>